These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

699 related items for PubMed ID: 16826359

  • 1. Human glioblastoma and carcinoma xenograft tumors treated by combined radiation and imatinib (Gleevec).
    Oertel S, Krempien R, Lindel K, Zabel A, Milker-Zabel S, Bischof M, Lipson KE, Peschke P, Debus J, Abdollahi A, Huber PE.
    Strahlenther Onkol; 2006 Jul; 182(7):400-7. PubMed ID: 16826359
    [Abstract] [Full Text] [Related]

  • 2. Combination of vascular endothelial growth factor receptor/platelet-derived growth factor receptor inhibition markedly improves radiation tumor therapy.
    Timke C, Zieher H, Roth A, Hauser K, Lipson KE, Weber KJ, Debus J, Abdollahi A, Huber PE.
    Clin Cancer Res; 2008 Apr 01; 14(7):2210-9. PubMed ID: 18381963
    [Abstract] [Full Text] [Related]

  • 3. STI571 (Gleevec) improves tumor growth delay and survival in irradiated mouse models of glioblastoma.
    Geng L, Shinohara ET, Kim D, Tan J, Osusky K, Shyr Y, Hallahan DE.
    Int J Radiat Oncol Biol Phys; 2006 Jan 01; 64(1):263-71. PubMed ID: 16274936
    [Abstract] [Full Text] [Related]

  • 4. Increased cure rate of glioblastoma using concurrent therapy with radiotherapy and arsenic trioxide.
    Ning S, Knox SJ.
    Int J Radiat Oncol Biol Phys; 2004 Sep 01; 60(1):197-203. PubMed ID: 15337556
    [Abstract] [Full Text] [Related]

  • 5. Trimodal cancer treatment: beneficial effects of combined antiangiogenesis, radiation, and chemotherapy.
    Huber PE, Bischof M, Jenne J, Heiland S, Peschke P, Saffrich R, Gröne HJ, Debus J, Lipson KE, Abdollahi A.
    Cancer Res; 2005 May 01; 65(9):3643-55. PubMed ID: 15867359
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of imatinib mesylate effects on glioblastoma aggressiveness with SPECT radiotracer 99mTc-(v)-DMSA.
    Le Jeune N, Dubois F, Bin V, Perek N.
    Eur J Cancer; 2006 May 01; 42(8):1004-13. PubMed ID: 16564690
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of alpha(v)beta3 integrin survival signaling enhances antiangiogenic and antitumor effects of radiotherapy.
    Abdollahi A, Griggs DW, Zieher H, Roth A, Lipson KE, Saffrich R, Gröne HJ, Hallahan DE, Reisfeld RA, Debus J, Niethammer AG, Huber PE.
    Clin Cancer Res; 2005 Sep 01; 11(17):6270-9. PubMed ID: 16144931
    [Abstract] [Full Text] [Related]

  • 8. Influence of imatinib mesylate on radiosensitivity of astrocytoma cells.
    Ranza E, Bertolotti A, Facoetti A, Mariotti L, Pasi F, Ottolenghi A, Nano R.
    Anticancer Res; 2009 Nov 01; 29(11):4575-8. PubMed ID: 20032406
    [Abstract] [Full Text] [Related]

  • 9. Response of U87 glioma xenografts treated with concurrent rapamycin and fractionated radiotherapy: possible role for thrombosis.
    Weppler SA, Krause M, Zyromska A, Lambin P, Baumann M, Wouters BG.
    Radiother Oncol; 2007 Jan 01; 82(1):96-104. PubMed ID: 17161482
    [Abstract] [Full Text] [Related]

  • 10. Enhancement of radiation sensitivity, delay of proliferative recovery after radiation and abrogation of MAPK (p44/42) signaling by imatinib in glioblastoma cells.
    Quick QA, Gewirtz DA.
    Int J Oncol; 2006 Aug 01; 29(2):407-12. PubMed ID: 16820883
    [Abstract] [Full Text] [Related]

  • 11. Antitumor interaction of short-course endostatin and ionizing radiation.
    Hanna NN, Seetharam S, Mauceri HJ, Beckett MA, Jaskowiak NT, Salloum RM, Hari D, Dhanabal M, Ramchandran R, Kalluri R, Sukhatme VP, Kufe DW, Weichselbaum RR.
    Cancer J; 2000 Aug 01; 6(5):287-93. PubMed ID: 11079167
    [Abstract] [Full Text] [Related]

  • 12. Irradiation combined with SU5416: microvascular changes and growth delay in a human xenograft glioblastoma tumor line.
    Schuuring J, Bussink J, Bernsen HJ, Peeters W, van Der Kogel AJ.
    Int J Radiat Oncol Biol Phys; 2005 Feb 01; 61(2):529-34. PubMed ID: 15667976
    [Abstract] [Full Text] [Related]

  • 13. Radiosensitization of squamous cell carcinoma by the alkylphospholipid perifosine in cell culture and xenografts.
    Vink SR, Lagerwerf S, Mesman E, Schellens JH, Begg AC, van Blitterswijk WJ, Verheij M.
    Clin Cancer Res; 2006 Mar 01; 12(5):1615-22. PubMed ID: 16533789
    [Abstract] [Full Text] [Related]

  • 14. Triple combination of irradiation, chemotherapy (pemetrexed), and VEGFR inhibition (SU5416) in human endothelial and tumor cells.
    Bischof M, Abdollahi A, Gong P, Stoffregen C, Lipson KE, Debus JU, Weber KJ, Huber PE.
    Int J Radiat Oncol Biol Phys; 2004 Nov 15; 60(4):1220-32. PubMed ID: 15519795
    [Abstract] [Full Text] [Related]

  • 15. Imatinib mesylate inhibits Leydig cell tumor growth: evidence for in vitro and in vivo activity.
    Basciani S, Brama M, Mariani S, De Luca G, Arizzi M, Vesci L, Pisano C, Dolci S, Spera G, Gnessi L.
    Cancer Res; 2005 Mar 01; 65(5):1897-903. PubMed ID: 15753388
    [Abstract] [Full Text] [Related]

  • 16. Enhancement of glioblastoma radioresponse by a selective COX-2 inhibitor celecoxib: inhibition of tumor angiogenesis with extensive tumor necrosis.
    Kang KB, Wang TT, Woon CT, Cheah ES, Moore XL, Zhu C, Wong MC.
    Int J Radiat Oncol Biol Phys; 2007 Mar 01; 67(3):888-96. PubMed ID: 17293239
    [Abstract] [Full Text] [Related]

  • 17. Impact of adjuvant inhibition of vascular endothelial growth factor receptor tyrosine kinases on tumor growth delay and local tumor control after fractionated irradiation in human squamous cell carcinomas in nude mice.
    Zips D, Hessel F, Krause M, Schiefer Y, Hoinkis C, Thames HD, Haberey M, Baumann M.
    Int J Radiat Oncol Biol Phys; 2005 Mar 01; 61(3):908-14. PubMed ID: 15708274
    [Abstract] [Full Text] [Related]

  • 18. Anti-Vascular endothelial growth factor treatment augments tumor radiation response under normoxic or hypoxic conditions.
    Lee CG, Heijn M, di Tomaso E, Griffon-Etienne G, Ancukiewicz M, Koike C, Park KR, Ferrara N, Jain RK, Suit HD, Boucher Y.
    Cancer Res; 2000 Oct 01; 60(19):5565-70. PubMed ID: 11034104
    [Abstract] [Full Text] [Related]

  • 19. Blockade of TGF-β signaling by the TGFβR-I kinase inhibitor LY2109761 enhances radiation response and prolongs survival in glioblastoma.
    Zhang M, Kleber S, Röhrich M, Timke C, Han N, Tuettenberg J, Martin-Villalba A, Debus J, Peschke P, Wirkner U, Lahn M, Huber PE.
    Cancer Res; 2011 Dec 01; 71(23):7155-67. PubMed ID: 22006998
    [Abstract] [Full Text] [Related]

  • 20. Recombinant human erythropoietin alpha improves the efficacy of radiotherapy of a human tumor xenograft, affecting tumor cells and microvessels.
    Lövey J, Bereczky B, Gilly R, Kenessey I, Rásó E, Simon E, Dobos J, Vágó A, Kásler M, Döme B, Tímár J, Tóvári J.
    Strahlenther Onkol; 2008 Jan 01; 184(1):1-7. PubMed ID: 18188516
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.